| 000 | 01850 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517183614.0 | ||
| 264 | 0 | _c20181003 | |
| 008 | 201810s 0 0 eng d | ||
| 022 | _a2146-8427 | ||
| 024 | 7 |
_a10.6002/ect.2016.0305 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNg, Zi Qin | |
| 245 | 0 | 0 |
_aA Proposed Classification System and Therapeutic Strategy for Chyle Leak After Laparoscopic Living-Donor Nephrectomy: A Single-Center Experience and Review of the Literature. _h[electronic resource] |
| 260 |
_bExperimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation _cApr 2018 |
||
| 300 |
_a143-149 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Review | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aChylous Ascites _xclassification |
| 650 | 0 | 4 |
_aDrainage _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 |
_aKidney Transplantation _xadverse effects |
| 650 | 0 | 4 |
_aLaparoscopy _xadverse effects |
| 650 | 0 | 4 | _aLiving Donors |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNephrectomy _xadverse effects |
| 650 | 0 | 4 |
_aOctreotide _xadministration & dosage |
| 650 | 0 | 4 |
_aParenteral Nutrition, Total _xadverse effects |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aReoperation |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTerminology as Topic |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aWestern Australia _xepidemiology |
| 700 | 1 | _aHe, Bulang | |
| 773 | 0 |
_tExperimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation _gvol. 16 _gno. 2 _gp. 143-149 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.6002/ect.2016.0305 _zAvailable from publisher's website |
| 999 |
_c27759528 _d27759528 |
||